• Login
  • Register
The Daily Sceptic
No Result
View All Result
  • Articles
  • About
  • Archive
    • ARCHIVE
    • NEWS ROUND-UPS
  • Podcasts
  • Newsletter
  • Premium
  • Donate
  • Log In
The Daily Sceptic
No Result
View All Result

The Inevitable Harms of Weight Loss Drugs

by Igho Onakpoya and Carl Heneghan
12 July 2023 2:00 PM

The European Union is investigating the reports of suicidal thoughts associated with the use of weight loss drugs Ozempic® (semaglutide) and Saxenda® (liraglutide). 

The U.S. FDA has received 60 reports of suicidal ideation for patients on semaglutide and 70 on liraglutide. 

Yet, Boris Johnson called semaglutide a “wonder drug” in his first Mail article as a columnist that he hoped would stop his fridge raids. Not a jot about the harm, though.

However, we previously showed in a systematic review that of 25 weight loss drugs approved by regulatory agencies between 1994 and 2003, all were subsequently withdrawn, mainly because of psychiatric or cardiovascular adverse drug reactions. Deaths were reportedly associated with seven products. 

The obsession with blockbuster weight loss drugs subsequently resulted in the development and approval of different groups of centrally acting drugs: the combination medications (naltrexone-bupropion and phentermine-topiramate) and lorcaserin.

But not much changed: again, we showed that the benefit-harm profile of these new drugs was no different from previously withdrawn medications with similar mechanisms of action. More participants who took the anti-obesity drugs achieved over 5% reduction in body weight. However, the products increased the risk of adverse events – one reported harm for every 11 people on the drug. A lot of folks also discontinued the medications because of these adverse events.

We later wrote in BMJ Evidence-Based Medicine that locaserin had minimal benefits and ill-defined harms. We weren’t the only ones – medical journal Prescrire had also warned of the unacceptable risks of the drug. It, therefore, wasn’t that surprising when lorcaserin was subsequently withdrawn from the market within a year of our publication because of an increased cancer risk.

We now find ourselves moving on to the next group of drugs – the approval of GLP-1 receptor agonists for weight loss agents – including Ozempic® and Saxenda®. While the evidence suggests that these drugs may promote weight loss, the potential harms of using such products are not extensively reported or investigated. There are hardly any post-marketing trials investigating their possible disadvantages.

While Johnson believed semaglutide could change the lives of millions, we’re not sure whether that is more likely to be through the small weight losses achieved or because of the harm to come. On average, we found that withdrawal of an obesity drug from the market takes about two years following the first report of an adverse reaction. 

We’re waiting to see what happens next, but don’t have much faith in our regulatory system as it is woeful for assessing harms. Most likely the drug will come with a safety warning, but history tells us what comes next is all too predictable.

Igho Onakpoya is a clinician and researcher with expertise in evaluating the benefits and harms of healthcare interventions. Dr. Carl Heneghan is the Oxford Professor of Evidence Based Medicine. This article was first published on Trust The Evidence, which you can subscribe to here.

 

Tags: Boris JohnsonMedicineMHRAObesityOzempicSafety

Donate

We depend on your donations to keep this site going. Please give what you can.

Donate Today

Comment on this Article

You’ll need to set up an account to comment if you don’t already have one. We ask for a minimum donation of £5 if you'd like to make a comment or post in our Forums.

Sign Up
Previous Post

Met Office Doubles Recent U.K. Warming Trend in Just 13 Months, Abolishing 15-Year Flatlining Trend

Next Post

The Shame of Being Debanked

Subscribe
Login
Notify of
Please log in to comment

To join in with the discussion please make a donation to The Daily Sceptic.

Profanity and abuse will be removed and may lead to a permanent ban.

28 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments

NEWSLETTER

View today’s newsletter

To receive our latest news in the form of a daily email, enter your details here:

DONATE

PODCAST

In Episode 35 of the Sceptic: Andrew Doyle on Labour’s Grooming Gang Shame, Andrew Orlowski on the India-UK Trade Deal and Canada’s Ignored Covid Vaccine Injuries

by Richard Eldred
9 May 2025
4

LISTED ARTICLES

  • Most Read
  • Most Commented
  • Editor’s Picks

Free Speech Union Helping 71 Year-Old ‘Thought Criminal’ Arrested by Kent Police and Held in Cell For Eight Hours

11 May 2025
by Toby Young

News Round-Up

12 May 2025
by Richard Eldred

Britain Faces Months-Long Blackouts Because of Net Zero

11 May 2025
by Richard Eldred

Oxford Union Rejects Call to Fly LGBT Flag During Pride Month

11 May 2025
by Richard Eldred

The Met Office is Unable to Name the Sites Providing ‘Estimated’ Temperature Data For its 103 Non-Existent Stations

12 May 2025
by Chris Morrison

Free Speech Union Helping 71 Year-Old ‘Thought Criminal’ Arrested by Kent Police and Held in Cell For Eight Hours

28

From “Horrific” to “Dogwhistle”: Lucy Powell’s Change of Tack About the Rape Gang Scandal

21

News Round-Up

19

Miliband Plots Surge in Wind Farm Subsidies to Rescue Net Zero

31

Britain Faces Months-Long Blackouts Because of Net Zero

18

Is Britain on the Brink of Civil War?

12 May 2025
by Joe Baron

From “Horrific” to “Dogwhistle”: Lucy Powell’s Change of Tack About the Rape Gang Scandal

12 May 2025
by Laurie Wastell

Declined: Chapter 18: The Unthinkable

11 May 2025
by Molly Kingsley

The Backlash to the War Against Boys

11 May 2025
by Noah Carl

Hugely Influential Covid Vaccine Study Claiming the Jabs Saved Millions of Lives Torn to Shreds in Medical Journal

10 May 2025
by Dr Raphael Lataster

POSTS BY DATE

July 2023
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
« Jun   Aug »

SOCIAL LINKS

Free Speech Union
  • Home
  • About us
  • Donate
  • Privacy Policy

Facebook

  • X

Instagram

RSS

Subscribe to our newsletter

© Skeptics Ltd.

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Articles
  • About
  • Archive
    • ARCHIVE
    • NEWS ROUND-UPS
  • Podcasts
  • Newsletter
  • Premium
  • Donate
  • Log In

© Skeptics Ltd.

wpDiscuz
You are going to send email to

Move Comment
Perfecty
Do you wish to receive notifications of new articles?
Notifications preferences